💊 › Ginekologia
[ENDOMETRIUM] - I linia - Dostarlimab 04.2025 [ENDOMETRIUM] - II+ linia - Dostarlimab/Pembrolizumab 04.2025 [JAJNIK] - I LINIA - olaparyb + bewacyzumab 04.2025 [JAJNIK] - I LINIA - olaparyb / niraparyb / rukaparyb 04.2025 [JAJNIK] - NAWROTOWY - Olaparyb 04.2025 [SZYJKA MACICY] Immunoterapia 01.2025

Leki z katalogu chemioterapii powiązane z tą kategorią:

Bevacizumab
C56C57
Bevacizumabum
C53
Bleomycin Sulphate
C53C55C56C57
Carboplatin
C53C54C55C56C57
Chlorambucilum
C56
Cisplatinum
C53C54C55C56C57
Cyklophosphamidum
C53C54C55C56C57
Dacarbazinum
C53C54C55C56C57
Docetaxelum
C56
Doxorubicinum
C53C54C55C56C57
Doxorubicinum Liposomanum Pegylatum
C56C57
Epirubicinum
C54C55C56C57
Etoposidum
C53C54C55C56C57
Fluorouracilum
C53C54C55C56C57
Gemcitabine
C54C56C57
Ifosfamidum
C53C54C55C56C57
Irinotecanum
C53C56
Melphalanum
C56
Methotrexatum
C56C57
Paclitaxel
C53C54C56C57
Tamoxifenum
C54C56
Topotecanum Inj.
C53C56
Trabectedin
C56C57
Trastuzumabum I.v.
C54
Vincristinum
C53C54C55C56C57
Vinorelbinum
C53C54C55C56C57